VTX-2337 in Combination With Radiotherapy in Patients Low-Grade B-cell Lymphomas
| Status: | Archived |
|---|---|
| Conditions: | Lymphoma |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
A Phase I/II Study of Intratumoral Injection of the Small Molecule TLR8 Agonist VTX-2337 in Combination With Local Radiation in Low-Grade B-cell Lymphomas
This study is to determine the safety and effectiveness of VTX-2337 (an investigational drug
that stimulates the immune system) in combination with radiation therapy in treating
patients with low-grade B-cell lymphoma. Patients will receive 2 low doses of radiotherapy,
and 9 intratumoral injections of VTX-2337 over the course of 3 months.
We found this trial at
1
site
Click here to add this to my saved trials
